Avantor AVTR Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Bioscience & Medtech Products | $451.8M-5.1% | $431.4M+1.2% | —— | —— | $475.9M— | |
| VWR Distribution & Services | $1.24B+2.7% | $1.15B-0.4% | —— | —— | $1.21B— | |
| Net Sales by Product | ||||||
| Proprietary | $880.4M-1.5% | $833.3M+0.4% | $869.8M-3.0% | $855.6M-7.1% | $893.8M-2.2% | |
| Third-party | $811.9M+2.8% | $748.1M-0.5% | $793.8M+0.5% | $768.2M-3.2% | $789.6M+0.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avantor break its business down?
- Avantor (AVTR) reports net sales by business across 2 parts — Bioscience & Medtech Products and VWR Distribution & Services. Each is extracted from the segment footnotes and tracked over time.
- Where does Avantor's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avantor's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
